Lupin Ltd is the pharmaceutical company that has to foray into diagnostics to leverage its ‘doctor connect to tap a sector that has low entry barriers, gives high returns on capital employed, and is witnessing double-digit growth. A formal launch is expected next month, media reported.
- NTPC Green Energy Adds 50 MW Solar Power in Rajasthan
- Coffee Day Enterprises Settles Rs 25 Cr Loan With Kemfin
- GST Collections Rise 14.7% to Rs 2.04 Lakh Crore in September
- GPT Infraprojects Bags Rs 385 Cr South Africa Rail Order
- Cabinet Backs Rs 1.86 Lakh Cr Plan for Green Power Grid
Lupin Diagnostics will be a part of Lupin Healthcare, a 100 per cent subsidiary of Lupin. It is in the process of recruiting the team, finalising franchise partners, and setting up a 45,000 square feet laboratory in Navi Mumbai.
Stock Covered in the news
Live
